ÂÜÀòÂÒÂ×

Jennifer Person has a diverse work experience in the healthcare industry. Jennifer is currently working as a Regional Sales Director at Biotheranostics, Inc. since August 2021. Prior to this, they served as a Regional Account Manager at the same company from January 2020 to June 2021.

Before joining Biotheranostics, Jennifer worked at Myriad Genetics, where they held multiple roles. Jennifer was an Oncology Product Consultant from July 2018 to January 2020, and earlier served as an Area Sales Manager from March 2013 to July 2018. Myriad Genetics is a leading personalized medicine company focused on molecular diagnostics.

Jennifer's earlier work experience includes a role as Chief Learning Officer at Richard James & Partners, LLC from August 2011 to March 2013. Jennifer was responsible for developing talent management strategies to achieve business success.

Jennifer also has extensive experience at TAKEDA PHARMACEUTICALS NORTH AMERICA, INC, where they held various positions. Jennifer worked as a District Sales Manager from February 2007 to August 2011, a Home Office Sales Trainer from March 2006 to February 2007, and as a Senior Professional Sales Representative from January 2002 to March 2006.

Overall, Jennifer Person has demonstrated their expertise in sales, account management, and leadership roles within the healthcare industry.

Jennifer Person, DBA has a strong educational background in business administration and education. Jennifer obtained their Doctorate of Business Administration in Strategy and Innovation from Capella University, where they studied from 2010 to 2013. Prior to that, they earned a Master of Science degree in Education from Indiana University Fort Wayne from 1998 to 2001. Their undergraduate education was completed at Western Michigan University, where they obtained a Bachelor of Science degree in Organizational Communication and Industrial Psychology in 1993.

In addition to their academic degrees, Jennifer also holds a certification in Integrity Coaching from Integrity Solutions, which they obtained in January 2011.